Functional dyspepsia in Yola, Nigeria

Authors

  • A. B. Olokoba
  • F. K. Salawu
  • J. A. Vickola

Keywords:

Functional dyspepsia, endoscopic, Nigerians

Abstract

Objective: Dyspepsia is a common disorder originating from the upper gastrointestinal tract, and is the most common indication for gastrointestinal endoscopy. Even though, functional dyspepsia (non-ulcer dyspepsia) is not life –threatening, it has profound clinical and economic effects, and influences the quality of life of sufferers. Data is scanty on functional dyspepsia from Nigeria. This study aims to determine the prevalence of functional dyspepsia in Yola, Nigeria.

Methods: This was a cross-sectional study carried out at the Gastroenterology unit of Federal Medical Centre, Yola from December, 2006 to October, 2010.

Patients with dyspepsia who had upper gastrointestinal endoscopy as part of their work-up were recruited. Their biodata, history and duration of dyspepsia were noted on a proforma. The spectrum of endoscopic findings was also noted.

Results: A total of 441 patients underwent upper gastrointestinal endoscopy out of which 299 patients had dyspepsia.  One hundred and thirteen (37.8%) were males while 186 (62.2%) were females, giving a male to female ratio of 1:1.6. The age range was from 18 to 97 years with a mean of 47.6 ± 9.4 years. Clinically significant endoscopic findings were seen in 94.0% while functional dyspepsia was seen in 18 patients (6.0%).

Conclusions: Functional dyspepsia was seen in only a minority of patients with dyspepsia.

References

Veldhuyzen van Zanten SJ, Flook N, Chiba N, Armstrong D, Barkin A, et al. An evidence-based approach to the management of patients with dyspepsia in the era of Helicobacter pylori. Can Med Assoc J 2000;162:S3-23.

Al-Humayed SM, Mohammed-Elbagir AK, Al-Wabel AA, Argobi YA. The c h a n g i n g p a t t e r n o f u p p e r

gastrointestinal lesions in Southern Saudi Arabia: An endoscopic study. Saudi J Gastroenterol2010; 16(1):35-37.

Olokoba AB, Bojuwoye BJ. Indications for oesophagogastroduodenoscopy in Ilorin, Nigeria - a 30 month review. Niger J Clin Pract 2010; 13(3):260-263.

Otegbayo JA, Adedapo A, Adedapo KS, Akere A, Aje AO, et al. Safety, Efficacy, and Tolerability of Meprasil in the treatment of dyspepsia among Nigerians. African Journal of Biomedical Research 2007;10:229-234.

Mustapha SK, Ajayi NA, Nggada HA,

Pindiga UH, Bolori MT, et al.

Endoscopic findings and the frequency of Helicobacter pylori among dyspeptic patients in Maiduguri, North-Eastern Nigeria. Highland Medical Research Journal. 2007;5(1):78-81.

Tytgat GN. Role of endoscopy and biopsy in the work up of dyspepsia. Gut. 2002; 50(suppl 4):13-16.

Tack J, Talley NJ, Camilleri M, Holtman G, Hu P, et al. Functional gastroduodenal d i s o r d e r s . G a s t r o e n t e r o l o g y

;130:1466-1479.

Talley NJ, Philips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med 1988; 108(6):865-879.

Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: A systemic review. Scand J GastroenterolSuppl 1999;231:3-8.

Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259-1268.

Jones RH, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-32.

Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment PharmacolTher 1996;10:83-89.

Shaib Y, El-serag HB. The prevalence and risk factors of functional dyspepsia in a multi-ethnic population in the United States. Am J Gastroenterol 2004; 99:2210-2216.

El-serag HB, Talley NJ. Systemic Review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmcol Ther 2004;19:643-654.

Wahass S, Khalil MS, Al Qurain AA, Yasawy MI. The impact of functional dyspepsia on health-related quality of life in Saudi patients. Saudi J Gastroenterol 2006;12(3):123-129.

Al Karawi MA, Ahmed AM, Shariq S, Mohammed AE. Evaluation of gastrooesophageal reflux disease results in 40 patients. Saudi Med J 1992;13:407-411.

Moayyedi P, Mason J. Clinical and economic consequences of dyspepsia in the community. Gut 2002;50(Suppl 4):10-12.

Halder SL, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Impact of functional gastrointestinal disorders on health-related quality of life:

A population-based case-control study. Aliment Pharmacol Ther 2004;19:233242.

El-serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2003;18:387393.

Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995;40:584-589.

Mones J, Adan A, Segu JL, Lopez JS, Artes M, Guerrero T. Quality of life in functional dyspepsia. Dig Dis Sci 2002;47:20-26.

Jemilohun AC, Otegbayo JA, Ola SO, Oluwasola OA, Akere A. Prevalence of Helicobacter pylori among Nigerian patients with dyspepsia in Ibadan. Pan Afr Med J 2010; 6:18.

Tijjani BM, Borodo MM, Samaila AA, Mohammed AZ. Helicobacter pylori infection in dyspeptic patients at Kano, Nigeria. Borno Medical Journal. 2005; 2(1): 14-17.

Thompson ABR, Barkun AN, Amstrong D, Chiba N, Whites RJ, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment- Prompt Endoscopy (CADETPE) study. Aliment Pharmacol Ther 2003; 17(12):1481-1491.

Olubuyide IO, Atoba MA, Ayoola EA. Dyspepsia in Ibadan. Trop Geogr Med 1989;41(4):337-340.

Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and teir relation to risk factors. Gut 1996;38(6): 822-825.

Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. W J G 2006;12(17):2661-6.

Suerbaum S, Michetti P, Helicobacter pylori infection. N Eng J Med 2002; 347(15):1175-1186.

Megraud F, Brassens-Rabbe MP, Denis F, Belbouri A, Hoa DQ. Seroepidemiology

of Campylobacter pylori infection in various populations. J Clin Microbiol 1989; 27(8):1870-1873.

Holcombe M, Umar H, Lucas SB, Kaluba J. Low incidence of clinically significant gastroduodenal pathology despite a high incidence of H. pylori infection. Trans R Soc Trop Med Hyg 1994; 88(5): 569-571.

Olokoba AB, Gashau W, Bwala S, Adamu A, Salawu FK. Helicobacter pylori infection in Nigerians with dyspepsia. Ghana Med J 2013;47(2):1-3.

Smith SI, Oyedeji KS, Goodluck HA, Fowora HA, Anomneze E, et al. The use of Helicobacter pylori stool antigen test for the diagnosis of Helicobacter pylori in Lagos, Nigeria. West Indian Med J 2011; 60(1):33-35.

Downloads

Published

2023-09-16

How to Cite

Olokoba, A. B., Salawu, F. K., & Vickola, J. A. (2023). Functional dyspepsia in Yola, Nigeria. Research Journal of Health Sciences, 3(1), 38–44. Retrieved from https://rjhs.org/index.php/home/article/view/80